ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Utility of slow conduction velocity area guided ablation in patients with persistent atrial fibrillation.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary vein isolation (PVI) is a well-established treatment for atrial fibrillation (AF). However, in patients with persistent AF, PVI alone is often insufficient, and no adjunctive strategy with proven efficacy beyond PVI has been established. Recently, increasing attention has been directed toward local atrial conduction velocity (CV). Slow conduction velocity areas (SCVAs) have been regarded as potential arrhythmogenic substrates, and ablation strategies targeting SCVAs are under investigation. This study evaluated the efficacy of SCVA-guided ablation in patients with persistent AF.
methodsWe enrolled 175 patients with persistent AF who underwent initial radiofrequency catheter ablation (RFCA). SCVAs were defined as contiguous atrial regions with a local CV < 0.7 m/s and a surface area ≥ 2.0 cm². SCVA-guided ablation was performed in 84 patients, whereas standard anatomical PVI was performed in 91 patients. The primary outcome was recurrence of AF or occurrence of new-onset supraventricular tachycardia during a two-year follow-up period.
resultsDuring follow-up, clinical recurrence occurred in 63 patients (36.0%). Patients in the SCVA-guided ablation group demonstrated a significantly higher recurrence-free survival rate compared with those in the standard PVI group (72.6% vs. 56.1%; log-rank P = 0.01). Multivariate analysis identified SCVA-guided ablation (hazard ratio [HR] 0.31, 95% confidence interval [CI] 0.21-0.67, P = 0.003) and left atrial (LA) volume index (HR 1.03, 95% CI 1.01-1.06, P = 0.001) as independent predictors of AF recurrence.
conclusionSCVAs represent important arrhythmogenic substrates. Incorporating these regions into PVI significantly reduced AF recurrence compared with standard anatomical PVI.
Indexed as
Identifiers
42258108What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.